Clonogenic mast cell progenitors and their excess numbers in chimeric BALB/c mice with inactivated GATA-1

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 47, 2007, Pages 18642-18647

  Metcalf, Donald ^a   Majewski, Ian ^a   Mifsud, Sandra ^a   Di Rago, Ladina ^a   Alexander, Warren S ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Eosinophil progenitors; Mast cell colonies; Mast cell lines

Indexed keywords

TRANSCRIPTION FACTOR GATA 1;

ANIMAL CELL; ARTICLE; CELL CLONE; CELL CULTURE; COLONY FORMING UNIT; CONTROLLED STUDY; GENE MUTATION; IN VIVO STUDY; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL COUNT; CELLS, CULTURED; EOSINOPHILS; GATA1 TRANSCRIPTION FACTOR; GENOTYPE; HEMATOPOIETIC STEM CELLS; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; STEM CELLS;

MUS;

EID: 36749095229     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0709625104     Document Type: Article

References (26)

1. Wedemeyer J, Tsai M, Galli SJ (2000) Curr Opin Immunol 12:624-631.
2. Kitamura Y, Ito A (2005) Proc Natl Acad Sci USA 102:11129-11130.
3. Chen CC, Grimbaldeston MA, Tsai M, Weissman IL, Galli SJ (2005) Proc Natl Acad Sci USA 102:11408-11413.
4. Pluznik DH, Sachs L (1966) Exp Cell Res 43:553-563.
5. Kirshenbaum AS, Goff JP, Metcalfe DD (1989) Immunology 68:120-125.
6. Pevny L, Lin CS, D'Agati V, Simon MC, Orkin SH, Costantini F (1995) Development (Cambridge, UK) 121:163-172.
7. Hirasawa R, Shimizu R, Takahashi S, Osawa M, Takayanagi S, Kato Y, Onodera M, Minegishi N, Yamamoto M, Fukao K, et al. (2002) J Exp Med 195:1379-1386.
8. Yu C, Cantor AB, Yang H, Browne C, Wells RA, Fujiwara Y, Orkin SH (2002) J Exp Med 195:1387-1395.
9. Migliaccio AR, Rana RA, Sanchez M, Lorenzini R, Centurione L, Bianchi L, Vannucchi AM, Migliaccio G, Orkin SH (2003) J Exp Med 197:281-296.
10. Masuda A, Hashimoto K, Yokoi T, Doi T, Kodama T, Kume H, Ohno K, Matsuguchi T (2007) J Immunol 178:360-368.
11. Majewski IJ, Metcalf D, Mielke LA, Krebs DL, Ellis S, Carpinelli MR, Mifsud S, Di Rago L, Corbin J, Nicola NA, et al. (2006) Proc Natl Acad Sci USA 103:14146-14151.
12. Berlanga O, Emambokus N, Frampton J (2005) Exp Hematol 33:403-412.
13. Metcalf D (1998) Proc Natl Acad Sci USA 95:6408-6412.
14. Nakahata T, Spicer SS, Cantey JR, Ogawa M (1982) Blood 60:352-361.
15. Kulessa H, Frampton J, Graf T (1995) Genes Dev 9:1250-1262.
16. Salmon JM, Slater NJ, Hall MA, McCormack MP, Nutt SL, Jane SM, Curtis DJ (2007) Blood, 10.1182/blood-2006-10-053124.
17. Metcalf D, Willson TA, Hilton DJ, Di Rago L, Mifsud S (1995) Leukemia 9:1556-1564.
18. Metcalf D, Begley CG, Nicola NA, Johnson GR (1987) Exp Hematol 15:288-295.
19. Rennick D, Hunte B, Holland G, Thompson-Snipes L (1995) Blood 85:57-65.
20. Pennock JL, Grencis RK (2004) Blood 103:2655-2660.
21. Ghinassi B, Sanchez M, Martelli F, Amabile G, Vannucchi AM, Migliaccio G, Orkin SH, Migliaccio AR (2007) Blood 109:1460-1471.
22. Metcalf D (2005) Blood Lines (AlphaMed, Durham, NC).
23. Alexander WS, Roberts AW, Nicola NA, Li R, Metcalf D (1996) Blood 87:2162-2170.
24. Glaser S, Metcalf D, Wu L, Hart, A. H., DiRago L, Mifsud S, D'Amico A, Dagger S, Campo C, Chan AC, et al. (2006) Proc Natl Acad Sci USA 103:16460-16465.
25. Roberts AW, Metcalf D (1995) Blood 86:1600-1605.
26. Yoshida H, Nishikawa SI, Okamura H, Sakakura T, Kusakabe M (1993) Develop Growth Differ 35:209-220.